Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Raised to $42 at BofA Securities

April 9, 2026 9:23 AM
BofA Securities analyst Jason Gerberry ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change